Esperion Therapeutics
ESPR
#6990
Rank
NZ$0.76 B
Marketcap
$3.87
Share price
0.69%
Change (1 day)
4.62%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -NZ$41.4 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.29 Billion. In 2023 the company made an earning of -NZ$0.27 Billion, an increase over its 2022 earnings that were of -NZ$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$41.4 Million-84.42%
2023 -NZ$0.27 Billion-15.03%
2022 -NZ$0.32 Billion-20.61%
2021 -NZ$0.4 Billion84.28%
2020 -NZ$0.22 Billion35.75%
2019 -NZ$0.16 Billion-55.71%
2018 -NZ$0.36 Billion19.57%
2017 -NZ$0.3 Billion125.39%
2016 -NZ$0.14 Billion51.43%
2015 -NZ$87.11 Million36.45%
2014 -NZ$63.85 Million43.55%
2013 -NZ$44.48 Million145.26%
2012 -NZ$18.14 Million
2002 -NZ$51.7 Million-7.81%
2001 -NZ$56.08 Million15.03%
2000 -NZ$48.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.88 Billion 1,617.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.69 B-1,455.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.27 B-24,136.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$8.78 B-17,304.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.13 Billion 136.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.39 Billion 649.15%๐Ÿ‡บ๐Ÿ‡ธ USA